You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -1,993.7% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.1 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 49.5 | n/a |
Price / Book value | 4.2 |
Latest | Forecast | |
---|---|---|
Revenue | 231.2% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-09-30 | 0.91 | -3.39 | -3.00p | -29.9 | 0.0 | n/a | n/a | 0.0% |
2020-09-30 | 0.46 | -4.95 | -4.70p | -21.7 | 0.0 | n/a | n/a | 0.0% |
2021-09-30 | 0.34 | -7.63 | -7.20p | -6.1 | 0.0 | n/a | n/a | 0.0% |
2022-09-30 | 0.15 | -7.57 | -6.70p | -1.7 | 0.0 | n/a | n/a | 0.0% |
2023-09-30 | 0.51 | -11.41 | -7.30p | -5.1 | 0.0 | n/a | n/a | 0.0% |
Director dealings: Oxford Biodynamics director lowers stake Sharecast News | 20 Oct |
---|---|
Oxford BioDynamics secures US billing code for prostate test Sharecast News | 03 Oct |
Oxford Biodynamics first-half losses widen Sharecast News | 30 May |
Holding(s) in Company | 25-Apr-24 14:50 |
---|---|
Holding(s) in Company | 11-Apr-24 22:40 |
Holding(s) in Company | 10-Apr-24 22:41 |
Holding(s) in Company | 09-Apr-24 22:46 |
Holding(s) in Company | 09-Apr-24 22:46 |